Screening for Multiple Autoantibodies in Plasma of Patients with Breast Cancer

Conclusion: Disease-relevant autoantibodies were detected in the plasma of patients with breast cancer and donors without breast cancer. This means that identifying the type and level of autoantibodies in samples will be important in determining their significance in the disease process. A microtiter plate-based array system could be a fast and inexpensive screening method for identifying and quantifying autoantibodies in human plasma.

Source: Cancer Genomics and Proteomics - November 6, 2017 Category: Cancer & Oncology Authors: BASSARO, L., RUSSELL, S. J., PASTWA, E., SOMIARI, S. A., SOMIARI, R. I. Tags: Reviews Source Type: research